Contact Us Careers Register
Coherent Market Insights

Platelet Aggregation Devices Market to Surpass US$ 959.7 Mn by 2031

Platelet Aggregation Devices Market to Surpass US$ 959.7 Mn by 2031 - Coherent Market Insights

Publish In : Nov 07, 2024

Report ID : CMI5393

Category : Medical Devices

Platelet Aggregation Devices Market to Surpass US$ 959.7 Mn by 2031

Platelet Aggregation Devices Market Can Witness Growth, Owing to Rising Cardiac Cases and Increasing Product Approvals

Platelet aggregation devices market is estimated to be valued at USD 611.7 Mn in 2024, exhibiting a CAGR of 6.6% over the forecast period (2024-2031). The market growth is driven by rising prevalence of cardiac diseases and growing product approvals. Furthermore, increasing investments by key players for development of advanced platelet aggregation testing devices can also drive the market growth.

Market Dynamics

Rising cardiac cases: Growing prevalence of cardiovascular diseases worldwide can drive the platelet aggregation devices market growth. In 2021, according to the WHO, cardiovascular diseases are the leading cause of deaths globally, with an estimated 17.9 million deaths due to CVD each year. This high disease burden has increased demand for platelet function testing devices for effective diagnosis and treatment.

Increasing Prevalence of Cardiovascular Diseases

Cardiovascular diseases such as heart attacks and strokes are major causes of mortality worldwide. Platelet aggregation devices play a key role in the pathogenesis of these diseases. As incidence of cardiovascular diseases rises due to changing lifestyles and aging population, there will be huge need for platelet aggregation devices for diagnosing and monitoring these conditions. This increasing disease burden can drive the platelet aggregation devices market growth.

Advancements in Platelet Function Testing Technologies

Manufacturers are continuously innovating and introducing novel platelet aggregation testing devices with improved functionality. For example, modern devices allow for faster, automated, and more accurate testing using smaller sample volumes. Some devices can also perform multiple tests simultaneously. Continuous technological enhancements are enabling these devices to deliver more precise and reproducible results. This expands the clinical applications of platelet aggregation testing and boosts demand for platelet aggregation devices.

High Cost of Advanced Devices

While basic platelet aggregometry devices are relatively affordable, high-end devices with advanced capabilities are quite expensive. High prices of these devices limit their adoption, especially in cost-sensitive developing regions.

Lack of Standardization

There has been lack of universally accepted standards for platelet function testing. Variations exist in pre-analytical and analytical methodologies between different manufacturers. This hinders direct comparison of test results and clinical interpretability. The absence of standardization poses challenges for researchers and regulatory bodies and can hamper the market growth.

Increasing Focus on Personalized Medicine

Precision or personalized medicine aims to tailor treatment based on an individual's genomic and molecular characteristics. Platelet function testing has applications in personalized antiplatelet therapy by enabling customization of drug choice and dosage regimens based on a patient's response. This emerging focus on personalized care presents lucrative opportunities.

Link - https://www.coherentmarketinsights.com/market-insight/platelet-aggregation-devices-market-5393

Key Developments

  • In February 2023, Terumo Corporation, a healthcare company, launched IMUGARD WB Platelet Pooling Set that supports extended shelf life of whole blood-derived platelets from five days to seven days. IMUGARD is the first platelet pooling set approved for seven-day storage in the U.S. and provides an alternate source of platelet supply at a time when demand continues to increase while the supply remains challenged by the lack of blood donors.
  • In May 2022, Precision BioLogic, a life science company, launched its CRYOcheck Chromogenic Factor IX assay for hemophilia B monitoring across the Europe, U.K., Australia, Canada, and New Zealand following regulatory approvals. This assay features a broad testing range, user-friendly design, and compatibility with automated analyzers, significantly enhancing hemophilia testing capabilities in these regions.

Key Players

Sysmex Corporation, WerfenLife SA, Siemens Healthineers, Sentinel Ch. SpA, Haemonetics Corporation, Chrono-Log Corporation, Bio/Data Corporation, Aggredyne Inc., F. Hoffmann-La Roche Ltd., and Helena Laboratories Corporation

ABOUT US:

Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.

CONTACT US:

Mr. Shah

Senior Client Partner – Business Development

Coherent Market Insights

PHONE:

UK: +44-203-957-8553 / +44-203-949-5508

US: +1-252-477-1362

AUS: +61-8-7924-7805

INDIA: +91-848-285-0837

Email: [email protected]

Follow Us: LinkedIn | Twitter

Need more?

Speak to our analyst to understand how this research was put together
Add more segments or countries to the scope as part of free customization
Understand how this report can have a direct impact on your revenue

  • Supplier Analysis
  • Value Chain Analysis
  • Demand Analysis
  • Customer Intelligence
  • Trade Analysis
  • Pricing Analysis

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports


Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Created billion dollars of revenue impact on thousands of clients

trusted clients logo

LogoCredibility and Certifications

Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.

Reliability and Reputation

860519526

Reliability and Reputation
ISO 9001:2015

9001:2015

ISO 27001:2022

27001:2022

Reliability and Reputation
Reliability and Reputation
© 2025 Coherent Market Insights Pvt Ltd. All Rights Reserved.
Enquiry Icon Contact Us